-+ 0.00%
-+ 0.00%
-+ 0.00%

Skye Bioscience Q1 EPS $(0.28) Beats $(0.31) Estimate

Benzinga·05/08/2025 20:07:35
Listen to the news
Skye Bioscience (NASDAQ:SKYE) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.31) by 9.68 percent.